Naik V, Darandale A, Pal P. Emerging Role of SGLT2 Inhibitors Beyond Glycemic Control: “Cardiovascular and Renal Benefits and Risks.” CARDIO . 2026;1(1):29-38. doi:10.64229/v3v43h95